tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market
IMDX
Insight Molecular Diagnostics
RESEARCH TOOLSreports
Want to see IMDX full AI Analyst Report?

Insight Molecular Diagnostics (IMDX) Stock News & Sentiment

435 Followers
Insight Molecular Corrects Bylaws Disclosure in Annual Report
Premium
Company Announcements
Insight Molecular Corrects Bylaws Disclosure in Annual Report
7d ago
8K
IMDX
Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
Premium
Ratings
Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
21d ago
IMDX
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
Premium
Company Announcements
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
1M ago
IMDX
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
Premium
Ratings
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
1M ago
IMDX
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
IMDX
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
Premium
Ratings
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
2M ago
IMDX
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
Premium
Company Announcements
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
2M ago
8K
IMDX
More IMDX News >

IMDX News on the Web

Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Insight Molecular Diagnostics (IMDX), Revolution Medicines (RVMD) and Travere Therapeutics (TVTX)
TipRanks News
Bullish
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Insight Molecular Diagnostics (IMDX) and Delcath Systems (DCTH)
TipRanks News
Neutral
Q4 2025 Insight Molecular Diagnostics Inc Earnings Call Transcript
GuruFocus News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Insight Molecular Diagnostics (IMDX), Tango Therapeutics (TNGX)
TipRanks News
Bullish
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
TipRanks News
Bullish
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
TipRanks News
Bullish

News Score - Last 7 Days

Positive
IMDX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMDX’s Media Buzz Sentiment?
2 articles about IMDX were published this week. In an average week, 2.25 articles are published.
    What is IMDX’s weekly average amount of articles?
    In an average week, 2.25 articles about IMDX are published.
      What is IMDX’s News Sentiment?
      100% of articles about IMDX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week